Posted by SLS on July 30, 2015, at 20:32:55
In reply to New Abilify approved for schizophrenia and depress, posted by Jeroen on July 30, 2015, at 17:15:58
I am guessing that cariprazine is better for negative symptoms and depression. It is more selective for D3 than D2 receptors. Unfortunately, the FDA has not approved it yet. Unless I see magic in brexpiprazole for others, I will be waiting for cariprazine to use as a substitute for Abilify.
- ScottSome see things as they are and ask why.
I dream of things that never were and ask why not.- George Bernard Shaw
poster:SLS
thread:1080861
URL: http://www.dr-bob.org/babble/20150629/msgs/1080871.html